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Abstract
We assessed the 6-min walk distance (6MWD) and body weight x distance product (6MWw) in healthy Brazilian subjects and 
compared measured 6MWD with values predicted in five reference equations developed for other populations. Anthropometry, 
spirometry, reported physical activity, and two walk tests in a 30-m corridor were evaluated in 134 subjects (73 females, 13-84 
years). Mean 6MWD and 6MWw were significantly greater in males than in females (622 ± 80 m, 46,322 ± 10,539 kg.m vs 551 
± 71 m, 36,356 ± 8,289 kg.m, P < 0.05). Four equations significantly overestimated measured 6MWD (range, 32 ± 71 to 137 
± 74 m; P < 0.001), and one significantly underestimated it (-36 ± 86 m; P < 0.001). 6MWD significantly correlated with age (r 
= -0.39), height (r = 0.44), body mass index (r = -0.24), and reported physical activity (r = 0.25). 6MWw significantly correlated 
with age (r = -0.21), height (r = 0.66) and reported physical activity (r = 0.25). The reference equation devised for walk distance 
was 6MWDm = 622.461 - (1.846 x Ageyears) + (61.503 x Gendermales = 1; females = 0); r2 = 0.300. In an additional group of 85 subjects 
prospectively studied, the difference between measured and the 6MWD predicted with the equation proposed here was not 
significant (-3 ± 68 m; P = 0.938). The measured 6MWD represented 99.6 ± 11.9% of the predicted value. We conclude that 
6MWD and 6MWw variances were adequately explained by demographic and anthropometric attributes. This reference equation 
is probably most appropriate for evaluating the exercise capacity of Brazilian patients with chronic diseases.
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The 6-min walk test (6MWT) is a simple tool for the 
evaluation of functional exercise capacity, which reflects the 
capacity of the individual to perform activities of daily living 
(1,2). Demographic, anthropometric, clinical, and physi-
ological characteristics can affect the test performance in 
healthy elderly subjects and in patients with cardiopulmonary 
diseases (3,4). Since the 6MWT is a self-paced test, the 
results are influenced by external factors such as energy 
expenditure, operator encouragement and subject motiva-
tion. Accordingly, the 6-min walk distance (6MWD) varies 
widely, even among healthy subjects (1,5). Therefore, the 
instructions and the level of verbal encouragement given 
must be carefully standardized (3). The American Thoracic 
Society (ATS) recommends that researchers establish 
specific reference values for each population (3). Recent 
studies have defined 6MWT reference values for various 
populations (6-10). However, previous studies have shown 
that equations used in other populations are not necessarily 
applicable to Brazilian subjects (11,12).
It has been suggested that 6-min walk work (6MWw), 
which is the product of 6MWD and body weight, can be used 
as an alternative means of measuring functional walking 
capacity (13). In patients with lung disease, the 6MWw rate 
has demonstrated better sensitivity and specificity in identify-
ing exercise intolerance than has 6MWD (14). Recently, Hill 
et al. (15) described 6MWw as an appropriate variable for 
estimating maximal exercise capacity in patients with chronic 
obstructive pulmonary disease during an incremental cycle 
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ergometer test. Thus, the 6MWw should be considered for 
a widespread evaluation of walking ability.
To our knowledge, there are no reference equations for 
predicting 6MWD in Brazilian subjects. Although the 6MWT 
has been validated for use in young Brazilian patients with 
chronic diseases, it is necessary to expand the evaluation 
of reference values to other populations and age brackets 
(16-19). In the present study, we assessed 6MWD and 
6MWw in a population-based sample of healthy subjects 
aged 13-84 years and established a reference equation to 
predict 6MWD and prospectively assess its reliability. We 
also compared the 6MWD values measured with those 
predicted by five reference equations devised for use with 
other populations.
Material and Methods
Screening
We studied 134 healthy subjects over 13 years of age. 
Volunteers were recruited from students and employees of 
the Federal University of São Paulo and from employees of 
the Santa Casa Hospital, both located in Santos, SP, Brazil, 
as well as from residents of the surrounding community. 
Reported physical activity (RPA) scores were collected 
from the subjects by means of the Baecke questionnaire 
(20), and subjects were classified as sedentary (score <8) 
or physically more active but still untrained (score ≥8). The 
volunteers were stratified into the following categories, 
based on body mass index (BMI): underweight (<18.5 kg/
m2), normal weight (18.5-24.9 kg/m2), overweight (25-29.9 
kg/m2), and obese (>30 kg/m2) (21). All subjects selected for 
study presented clinical stability, defined as the absence of 
any acute disease during the 6 weeks preceding the study. 
Subjects with abnormal post-bronchodilator lung function, 
i.e., forced expiratory volume in one second (FEV1) <80% 
of the predicted value or forced vital capacity (FVC)/FEV1 
ratio <70%, were excluded, as were those with a current 
diagnosis of cardiovascular/respiratory disease, those 
with any health problem that might interfere with the abil-
ity to perform physical exercises (e.g., impaired cognition, 
metabolic, neuromuscular or musculoskeletal diseases, 
or use of walking aids), and those regularly using medica-
tions for chronic diseases. However, those with controlled 
arterial hypertension, as well as former smokers without 
tobacco-related diseases, were included in the study. To 
verify the reliability of our 6MWD reference equation, we 
prospectively measured 6MWD in a second group of 85 
additional healthy adults (45 women) at another center lo-
cated in the Botucatu Medical School (UNESP, São Paulo 
State University), Botucatu, Brazil. As done in Santos, these 
volunteers were recruited among students and employees 
from the University and the surrounding community. They 
met the study inclusion criteria and had not participated in 
the first part of the study. Total body mass (kg) and body 
height (cm) were measured according to standard tech-
niques, with the subjects wearing light clothing and no shoes 
(22). Measurements were made with a calibrated Filizola 
scale (0.1 kg of precision) and with a stadiometer (0.5 cm 
of precision) and the BMI (body masskg body heightm2) was 
calculated. Subsequently, the volunteers completed the 
physical activity readiness questionnaire (23). The risk for 
cardiovascular events during exercise was assessed ac-
cording to the recommendations of the American College 
of Sports Medicine (24). On the basis of age, health status, 
symptoms, and cardiovascular risk factors, the volunteers 
were stratified into two risk levels, i.e., low and moderate. 
Subjects presenting high risk were excluded.
Pulmonary function and reversibility tests were per-
formed using a spirometer (Spirodoc; Medical International 
Research, Rome, Italy), according to the criteria established 
by the ATS (25). FEV1 values are reported as percentages 
of reference values (26). 
The study design was approved by the Human Re-
search Ethics Committee of the Federal University of São 
Paulo, and all subjects gave written informed consent to 
participate.
Six-minute walk test
Each subject was instructed to walk as far as possible 
during a 6-min period over a 30-m course in an indoor 
hospital corridor. Following a rest of at least 30 min, each 
subject performed a second 6MWT in the same manner 
as the first. The course was identified by two traffic cones, 
and the corridor was marked every 3 m according to ATS 
standards (3). Instructions and verbal encouragement given 
to the subjects were standardized. Encouragement was 
given every minute during the test until subject exhaustion. 
The end of the test was determined either by the subject, 
for any reason, or by the physical therapist conducting 
the test. Chest pain, intolerable dyspnea, dizziness, leg 
cramps, diaphoresis, and pallor were additional criteria for 
immediately stopping the test. The results of the second 
test were recorded for analysis. Before and after each test, 
the following data were obtained: pulse rate; respiratory 
rate; blood pressure, and dyspnea/leg effort, using the Borg 
scale (27). Measured 6MWD values were compared with 
predicted values using five reference equations devised 
for use in other populations (1,5,6,28,29).
Statistical analysis
Statistical analysis was performed using the statistical 
package SigmaStat 2.03 (SPSS, Chicago, IL, USA). Data 
are reported as mean ± standard deviation (SD) or as median 
(interquartile range). The following tests were performed: 
Kolmogorov-Smirnov, for descriptive data analysis; calcula-
tion of variation (∆) in the absolute values for the variables 
studied, Pearson or Spearman coefficient to evaluate 
the correlations between the studied variables, unpaired 
Student t-test or Mann-Whitney test for comparisons be-
tween means, and multiple linear regression (dependent 
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variable: 6MWD; independent variables: demographic and 
anthropometric attributes). The reliability of our 6MWD 
reference equation was evaluated in the second group 
of 85 healthy adults. We compared the measured 6MWD 
with the predicted distance derived from our equation. The 
predicted maximal heart rate (HRmax) was calculated using 
the following equation: 220 - ageyears.
Results
Of the 134 subjects evaluated, 73 (54.4%) were fe-
males. The mean age of the sample was 36 ± 15 years. All 
individuals studied presented normal lung function (FEV1 
= 94 ± 8%; FVC = 93 ± 9%; FEV1/FVC = 92 ± 12%). Mean 
BMI was within the normal range (25 ± 4 kg/m2) (21). Ac-
cording to reference cut-off points, 3.1% were classified as 
underweight, 46% were classified as normal weight; 37.6% 
were classified as overweight, and 12.5% were classified 
as obese. The prevalence of smoking was 19.4%. The 
mean 6MWD for the second test was 583 ± 83 m (range: 
417-828 m), compared with 577 ± 80 m (range: 397-840 
m) for the first test, and the difference between the two 
was not statistically significant (P = 0.584). During the 
6MWT, subjects reached 65 ± 13% of their HRmax (range: 
38-98%). Mean 6MWw was 40,893 ± 10,588 kg·m (range: 
20,600-71,572 kg·m).
The characteristics of the 134 subjects are summarized 
in Table 1. Weight, height, RPA, %HRmax at the end of 
the 6MWT, 6MWD, and 6MWw were greater in males than 
in females. There was no significant difference between 
males and females in terms of BMI. Comparisons and cor-
relations between measured 6MWD values and predicted 
values using previously established reference equations 
are presented in Table 2. With the exception of that de-
vised by Enright and Sherrill (1), all equations evaluated 
overestimated 6MWD values in relation to those obtained 
in the present study.
The mean walking distance prospectively measured 
in 85 subjects (41 ± 13 years, 165 ± 8 cm, 66 ± 12 kg, 
and 24 ± 4 kg/m2) was 571 ± 74 m, representing 99.6 ± 
11.9% of the predicted value calculated with our reference 
equation for 6MWD: 6MWDm = 622.461 - (1.846 x Ageyears) 
+ (61.503 x Gendermales = 1; females = 0). The mean walking 
distance predicted by means of our reference equation 
was 575 ± 38 m. The difference between prospectively 
measured and predicted 6MWD in these subjects was not 
significant (-3 ± 68 m) and the correlation was significant 
(r = 0.54; P < 0.0001). 
Univariate analysis showed that 6MWD correlated sig-
nificantly (P < 0.05) with age, height and BMI (Figure 1), as 
well as with FEV1L (r = 0.65; P < 0.0001), FVCL (r = 0.65; 
P < 0.0001) and RPA (r = 0.25; P < 0.01). In the multiple 
linear regression analysis, age and gender were selected as 
predictors of 6MWD, jointly explaining 30% of the total vari- 
Table 2. Comparisons and correlations between measured and predicted 6-min walk distance using other refer-
ence equations in subjects participating in the first part of the study (N = 134).
Equation N Measured 6MWD 
(m)
Predicted 6MWD 
(m)
Predicted - 
measured (m)
% Predicted Correlation (r)
Gibbons et al. (28) 122 657 (512-645) 716 (665-773)* 137 ± 74 80 ± 10 0.50+
Chetta et al. (6) 104 581 (526-648) 624 (594-657)*   32 ± 71 94 ± 11 0.48+
Enright and Sherrill (1)   49 543 ± 71 506 ± 75*  -36 ± 86 109 (95-116) 0.31#
Troosters et al. (5)   31 534 (482-621) 600 (570-663)*   71 ± 76 88 (81-93) 0.47#
Camarri et al. (29)   22 536 (480-630) 653 (634-702)* 115 ± 67 82 ± 10 0.55#
Data are reported as median (Interquartile range), with the exception of some related to the Enright and Sherril equa-
tion, which are reported as means ± SD. 6MWD = 6-min walk distance. *P < 0.001: measured vs predicted 6MWD; 
+P < 0.001: significant correlation; #P < 0.05: significant correlation (Spearman rank order correlation: Gibbons et al. 
and Camarri et al.; Pearson product moment correlation: Chetta et al., Enright and Sherrill and Troosters et al.).
Table 1. Characteristics of the study subjects.
Characteristic Males (N = 61)
Females 
(N = 73)
Age in years, median (Interquartile range) 31 (22-37) 35 (24-52)
Height in cm, mean ± SD 172 ± 70 159 ± 6*0
Weight in kg, median (Interquartile range) 72 (65-84) 65 (57-73)*
BMI in kg/m2, median (Interquartile range) 24 (22-27) 25 (23-29)
RPA, mean ± SD   9.0 ± 1.8   7.6 ± 1.4*
6MWD in m, mean ± SD 622 ± 80 551 ± 71*
%HRmax, median (Interquartile range) 60 (53-69) 68 (61-76)*
6MWw in kg·m, median 
(Interquartile range)
45,000 
(38,761-53,956)
34,790 
(30,749-41,966)* 
BMI = body mass index; RPA = reported physical activity (Baecke 
questionnaire); HRmax = maximal heart rate; 6MWD = 6-min 
walk distance; 6MWw = body weight x walk distance product. *P 
< 0.05 compared to males (Student t-test or Mann-Whitney test).
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ance in 6MWD (Table 3). Age and height correlated sig-
nificantly with 6MWw (Figure 1), as did FEV1L (r = 0.67; P 
< 0.0001), FVCL (r = 0.66; P < 0.0001) and RPA (r = 0.25; 
P < 0.01). 
Thus, we propose the new reference equation cited 
above for 6MWD. 
Discussion
To our knowledge, the present study is the first to in-
vestigate predicted values and potential demographic and 
anthropometric determinants of 6MWD and 6MWw in the 
Brazilian population and to propose a predictive equation. 
Figure 1. Significant correlations between walk-
ing performance and the following variables: 
6MWD with age (A), height (B), and BMI (C); 
6MWw with age (D) and height (E) (Pearson 
product moment correlation). 6MWD = 6-min 
walk distance; BMI = body mass index; 6MWw = 
6-min walk work (distance x body weight).
Table 3. Predictive model for the total distance walked in the 
6-min walk test in healthy subjects.
Variable Coefficient SEM P 95% confidence interval
Minimum Maximum
Constant 622.461 18.053 <0.001  0.011613 1244.910387
Age, years -1.846 0.416 <0.001 -0.000624 -3.691376
Gender* 61.503 12.491 <0.001 -0.002684 123.008684
*Gender factor: males = 1; females = 0. 6MWD = 6-min walk 
distance. Reference equation proposed here: 6MWDm = 622.461 
- (1.846 x Ageyears) + (61.503 x Gendermales = 1; females = 0); r2 = 0.300 
(standard error of the estimate = 70.992 m).
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Reference equations would permit a more appropriate 
evaluation of Brazilian patients with chronic diseases that 
affect exercise capacity. The equations derived from other 
populations commonly overestimated 6MWD in relation to 
the values obtained for our subjects. Since we adhered to 
the guidelines for the 6MWT, established in 2002 (3), we 
believe that the results of the present study contribute to 
facilitating the international comparison of 6MWD values.
Age, height, BMI, and gender significantly influenced the 
6MWD of our volunteers. After multiple regression analy-
sis, only age and gender were selected as determinants 
of 6MWD. These findings agree with those of previous 
studies (6,28). The negative influence of advanced age on 
the 6MWD might be explained by the gradual reduction in 
muscle mass, muscle strength and maximal oxygen uptake 
that typically occurs with aging. The influence of gender on 
6MWD might be attributable to the greater absolute muscle 
strength, muscle mass and height of men compared to 
women. Our finding that height influences 6MWD agrees 
with the correlations between height and 6MWD (range: r 
= 0.20 to r = 0.54) reported by others (1,5,7,28). This can 
be attributed to the greater stride length of taller individuals, 
stride length being a major predictor of gait speed (30). We 
found only a weak correlation between BMI and 6MWD. This 
correlation has been previously shown to be nonlinear (4). 
Obesity increases 6MWw, 6MWD being shorter in subjects 
with greater body weight or higher BMI (4). 
In our study, the reference equation for predicting 6MWD 
presented a squared correlation coefficient of 0.300, similar 
to values reported in previous studies, in which it ranged 
from 0.300 to 0.660 (4,5). Age, height and gender influenced 
the 6MWw. In fact, 6MWw has been shown to correlate 
with change in oxyhemoglobin desaturation during walk-
ing, with the anaerobic threshold and with maximal oxygen 
uptake (13). Our results suggest that 6MWw is important 
for evaluating walking performance.
Potential sources of 6MWD variance other than age, 
gender or height should be considered. One such source 
is the psychological status related to exercise capacity in 
healthy subjects and in patients with pulmonary disease 
(3). Other potential sources are differences in peripheral 
muscle conditioning (4,31) and in pulmonary function (29). 
However, these variables are not as easily assessed as 
are demographic and anthropometric attributes, since 
dynamometers and spirometers are necessary to quantify 
muscle and pulmonary function, respectively.
We observed that the equations devised by Troosters 
et al. (5), Chetta et al. (6), Gibbons et al. (28), and Camarri 
et al. (29) overestimated 6MWD in relation to the values 
obtained for our sample. The cause of the pronounced dif-
ference between the measured and predicted 6MWD values 
might have been multifactorial. Both the standardization of 
the test and ethnic characteristics should be considered. 
Among the studies, corridor length varied from 20 m to 50 
m and the number of pre-tests for familiarization varied from 
two to four (5,28,29,32). The level of encouragement might 
also have influenced the results, since guidelines other than 
those established by the ATS (33,34) were used in some 
studies (1,5,29,32). The only equation that underestimated 
our measured 6MWD was derived from only one test (i.e., 
without practice) (1). On the other hand, Chetta et al. (6), 
who adhered to ATS guidelines, devised an equation that 
only slightly overestimated 6MWD in relation to our find-
ings. These discrepancies may be attributed to population 
differences between samples. Our volunteers were slightly 
shorter and our women volunteers had a greater body weight 
when compared to the subjects studied by Chetta et al. (6). 
These differences emphasize the importance of developing 
population-specific reference equations. Accordingly, our 
additional prospective data confirmed the equation’s reli-
ability and also illustrated the errors that could arise from 
using other equations for the Brazilian population. Therefore, 
we propose that our reference equation should be used in 
the Brazilian population.
Some potential limitations of our study should be con-
sidered. Both study centers evaluated volunteers for the 
elaboration of the reference equation and for its validation. 
Although subjects were selected consecutively when they 
fulfilled the inclusion criteria, such a convenience sample 
might have introduced a bias. However, the prevalence 
of sedentary lifestyle (52.23%) and obesity (12.5%) ob-
served in the present study population agrees with the 
values previously reported for healthy Brazilian subjects 
(21,35). In addition, convenience samples have often been 
included in studies evaluating reference values for 6MWD 
(1,4-8,10,28,29). Although the sample size was sufficient 
to elaborate a reference equation, we evaluated a relative 
small sample in the present study to produce reference 
values. Nevertheless, our study should be repeated with 
larger samples. 
We conclude that 6MWD and 6MWw present substantial 
variability in healthy subjects aged 13-84 years. However, an 
important part of the variability was adequately predicted by 
demographic and anthropometric attributes. We observed 
that equations devised for other populations overestimated 
the 6MWD measured in Brazilian subjects. This study re-
sulted in a reference equation for the prediction of 6MWD 
in healthy subjects, and this equation can facilitate the 
assessment of Brazilian patients with diseases that affect 
their exercise capacity.
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